AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Tata Elxsi Q3 FY26: Revenue up 3.9% QoQ to ₹953.5 Cr, EBITDA grows 15% QoQ

Tata Elxsi Limited

AI Sentiment Analysis

January 13, 2026, 12:44 PM

Top Queries to Ask About Tata Elxsi Limited

Thinking to buy or sell Tata Elxsi Limited? Ask AI before you act.

Users

Trusted by 5,000+ users

More Details on This News

Tata Elxsi Limited announced its financial results for the third quarter and nine months ended December 31, 2025. The company reported revenue from operations of ₹953.5 crore, marking a 3.9% increase quarter-on-quarter (QoQ) and a 1.5% year-on-year (YoY) growth.

EBITDA for the quarter stood at ₹222.2 crore, representing a 15.0% increase QoQ and a 9.9% decrease YoY. The EBITDA margin improved by 220 basis points QoQ to 23.3%. Profit Before Tax (PBT) was ₹242.0 crore, up 12.7% QoQ but down 5.4% YoY. Profit After Tax (PAT) was ₹179.1 crore, a 15.7% increase QoQ, but a 10.0% decrease YoY.

The company's transportation business was a key growth driver, with accelerated ramp-ups in SDV-led OEM deals and normalization of workstreams with a strategic OEM client. Growth in regions was led by Europe and the US. The Media and Communications, and Healthcare and Life Sciences verticals experienced seasonal furloughs and delayed deal awards, with recovery expected from Q4 FY26.

Manoj Raghavan, CEO and MD, highlighted the operational excellence in improving margins and the continued investment in Gen AI and AI for innovation. He expressed confidence in growth for the upcoming quarter and the next financial year, backed by strategic customer shifts, new client additions, large deal wins, and investments in future-forward technologies.

The investor presentation and fact sheet for the quarter ended December 31, 2025, have been submitted to the BSE and NSE. The company also detailed several key deals won in Q3 FY26, including a multi-year network transformation deal with a European Telco, a regulatory workflow transformation deal for a global MedTech leader, and projects for a leading publisher, a US healthcare leader, and a US off-highway OEM.

More News on Tata Elxsi Limited

Analyze Tata Elxsi Limited

Discover more trending news on Prysm

View All